The progression of Alzheimer’s disease has been associated with alterations in the phosphorylation state of nuclear tau, indicating that the functional impairment of nuclear tau could be a significant pathological event (Abasi et al., 2024; Gil et al., 2020; Hernández-Ortega et al., 2016). This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.